Antidiabetic Activity of Zn(II) Complexes with a Derivative of L-Glutamine

DOI PDF Web Site 56 References
  • Matsumoto Kinuyo
    Laboratory of Nutrition Physiology, Graduate School of Life Science, Kobe Women’s University
  • Yamamoto Shuhei
    Department of Chemistry, Graduate School of Science, Osaka City University
  • Yoshikawa Yutaka
    Department of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University
  • Doe Matsumi
    Department of Chemistry, Graduate School of Science, Osaka City University
  • Kojima Yoshitane
    Department of Chemistry, Graduate School of Science, Osaka City University
  • Sakurai Hiromu
    Department of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University
  • Hashimoto Hiroko
    Laboratory of Nutrition Physiology, Graduate School of Life Science, Kobe Women’s University
  • Kajiwara Naemi M.
    Laboratory of Nutrition Physiology, Graduate School of Life Science, Kobe Women’s University

Bibliographic Information

Other Title
  • Antidiabetic Activity of Zn 2 Complexes with a Derivative of L Glutamine
  • Antidiabetic Activity of Zn(II) Complexes with a Derivative of <scp>l</scp>-Glutamine

Search this article

Description

The insulinomimetic activity of zinc(II) complexes Zn(gln-m)2 and Zn(gln-e)2, respectively, with L-γ-glutamyl-methylamide (gln-m) and -ethylamide (theanine: gln-e), components of green tea, were compared to that of Zn(gln)2 with L-glutamine (gln) in an in vitro study using isolated rodent adipocytes treated with epinephrine in the presence of glucose, expressed as the IC50 value (50% inhibition concentration) of free fatty acids (FFA) released from fat cells. The former were found to have higher inslinomimetic activity than that of the latter. The IC50 values of the former were 0.61 and 0.56, respectively. Then, the anti-diabetic activity of a zinc(II) complex, Zn(gln-e)2, was examined in an in vivo experiment on KK-Ay mice, model animals of type-2 DM, by the intraperitoneal (ip) injection of 3–4 mg Zn/kg b.w./day for 13 days. The blood-glucose level of a group treated with a Zn complex, Zn(gln-e)2, decreased significantly after 13 days compared to those of non-treated and gln-e treated groups. The serum concentrations of triglyceride (TG) and HbA1c decreased significantly in Zn(gln-e)2 treated KK-Ay mice compared to those of the gln-e treated group, respectively. Furthermore, the improvement in glucose tolerance was confirmed by an oral glucose tolerance test.

Journal

References(56)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top